Phase I Study of AbGn-168H in Healthy Male Volunteers

single very low dose of AbGn-168H i.v.

single low dose of AbGn-168H i.v.

single dose of Placebo i.v.

single dose of Placebo i.v.

single dose of Placebo i.v.

single dose of Placebo i.v.

single medium dose of AbGn-168H i.v.

single high dose of AbGn-168H i.v.

single low dose of AbGn-168H s.c.

single dose of Placebo s.c.

single dose of Placebo s.c.

single medium dose of AbGn-168H s.c.